[Hair changes in immunosuppressive therapy].
D000970:Antineoplastic Agents / Q000009:adverse effects; D001379:Azathioprine / Q000009:adverse effects; D002699:Chlorambucil / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D006197:Hair / Q000187:drug effects / Q000473:pathology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008558:Melphalan / Q000009:adverse effects; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D012871:Skin Diseases / Q000209:etiology* / Q000473:pathology; D014747:Vinblastine / Q000009:adverse effects
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001379:Azathioprine; D008558:Melphalan; D008727:Methotrexate
Haarveränderungen bei immunsuppressiver Therapie.